Anne-Marie Van Dam Selected Research

Dementia (Dementias)

1/2007

(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne-Marie Van Dam Research Topics

Disease

5	Inflammation (Inflammations) 01/2021 - 06/2002
5	Multiple Sclerosis 11/2015 - 04/2005
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 04/2005
2	Pain (Aches) 01/2022 - 01/2021
2	Neuralgia (Stump Neuralgia) 01/2021 - 05/2015
2	Hyperalgesia 01/2021 - 05/2015
2	Neuroinflammatory Diseases 01/2021 - 08/2007
2	Brain Diseases (Brain Disorder) 01/2021 - 05/2015
1	Memory Disorders (Memory Loss) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 03/2020
1	Ataxia (Dyssynergia) 03/2020
1	Atrophy 03/2020
1	Gliosis 03/2020
1	Nervous System Diseases (Neurological Disorders) 03/2020
1	Paralysis (Palsy) 05/2015
1	Encephalomyelitis (Myeloencephalitis) 08/2014
1	Demyelinating Diseases (Demyelinating Disease) 01/2013
1	Neuroblastoma 06/2011
1	Parkinson Disease (Parkinson's Disease) 06/2011
1	Alzheimer Disease (Alzheimer's Disease) 01/2007
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2007
1	Infections 01/2007
1	Necrosis 01/2007
1	Dementia (Dementias) 01/2007
1	Bacterial Meningitis 01/2007
1	Brain Ischemia (Cerebral Ischemia) 07/2004
1	Stroke (Strokes) 07/2004
1	Fever (Fevers) 06/2002

Drug/Important Bio-Agent (IBA)

4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 07/2004
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
3	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 04/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2005
2	Protein Glutamine gamma Glutamyltransferase 2IBA 11/2015 - 06/2011
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2013 - 07/2004
2	CytokinesIBA 01/2007 - 06/2002
2	ChemokinesIBA 01/2007 - 04/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007 - 09/2005
2	Interleukin-1beta (Interleukin 1 beta)IBA 09/2005 - 06/2002
1	Neutralizing AntibodiesIBA 01/2022
1	NLR ProteinsIBA 01/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Toll-Like Receptor 2IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Naltrexone (ReVia)FDA LinkGeneric 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	Glutens (Glutelin)IBA 03/2020
1	Multifunctional EnzymesIBA 11/2015
1	Adenosine (Adenocard)FDA LinkGeneric 05/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2014
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 08/2014
1	IonophoresIBA 06/2011
1	EnzymesIBA 06/2011
1	AminesIBA 06/2011
1	SynucleinsIBA 06/2011
1	Calcimycin (A23187)IBA 06/2011
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2007
1	Interleukin-6 (Interleukin 6)IBA 09/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2005
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2005
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2005
1	G-Protein-Coupled Receptor Kinase 2IBA 04/2005
1	NeuropeptidesIBA 04/2005
1	Neuroprotective AgentsIBA 07/2004
1	LipopolysaccharidesIBA 06/2002
1	InterleukinsIBA 06/2002
1	Interleukin-10 (Interleukin 10)IBA 06/2002

Therapy/Procedure

1	Spinal Injections 01/2022
1	Therapeutics 01/2021
1	Intraventricular Infusions 06/2002